Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilad Ofek

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Nature Communications|February 11, 2026
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Plos One|June 15, 2016
Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8Cinque Soto, Gilad Ofek, M Gordon Joyce, et al.
Nature|November 16, 2012
Broad and potent neutralization of HIV-1 by a gp41-specific human antibodyJinghe Huang, Gilad Ofek, Leo Laub, et al.
Plos One|December 6, 2011
Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41S Moses Dennison, Laura L Sutherland, Frederick H Jaeger, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2013
Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chainsJiang Zhu, Gilad Ofek, Yongping Yang, et al.
Journal of Virology|September 2, 2011
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodiesZhongyu Zhu, Haiyan Rebekah Qin, Weizao Chen, et al.
Science (New York, N.Y.)|May 11, 2013
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationIvelin S Georgiev, Nicole A Doria-Rose, Tongqing Zhou, et al.
Nature|October 9, 2014
Structure and immune recognition of trimeric pre-fusion HIV-1 EnvMarie Pancera, Tongqing Zhou, Aliaksandr Druz, et al.
Journal of Virology|April 8, 2016
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignYoung D Kwon, Ivelin S Georgiev, Gilad Ofek, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Communications|February 11, 2026
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine designLinling He, Yi-Zong Lee, Yi-Nan Zhang, et al.
Plos One|June 15, 2016
Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8Cinque Soto, Gilad Ofek, M Gordon Joyce, et al.
Nature|November 16, 2012
Broad and potent neutralization of HIV-1 by a gp41-specific human antibodyJinghe Huang, Gilad Ofek, Leo Laub, et al.
Plos One|December 6, 2011
Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41S Moses Dennison, Laura L Sutherland, Frederick H Jaeger, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2013
Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chainsJiang Zhu, Gilad Ofek, Yongping Yang, et al.
Journal of Virology|September 2, 2011
Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodiesZhongyu Zhu, Haiyan Rebekah Qin, Weizao Chen, et al.
Science (New York, N.Y.)|May 11, 2013
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralizationIvelin S Georgiev, Nicole A Doria-Rose, Tongqing Zhou, et al.
Nature|October 9, 2014
Structure and immune recognition of trimeric pre-fusion HIV-1 EnvMarie Pancera, Tongqing Zhou, Aliaksandr Druz, et al.
Journal of Virology|April 8, 2016
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based DesignYoung D Kwon, Ivelin S Georgiev, Gilad Ofek, et al.
JCI Insight|January 31, 2020
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functionsDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Pageof 4